Related Experiment Video

Updated: Jul 9, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Bronchiolitis: the new American Academy of Pediatrics guidelines

G Corsello1

  • 1Pediatrics and Neonatal Intendive Care Unit, Università de Palermo, Italy.

Journal of Chemotherapy (Florence, Italy)
|April 17, 2008
PubMed

Insights

Respiratory Syncytial Virus (RSV) causes severe lower respiratory tract infections in young children globally. Factors like birth details and environmental exposures may influence RSV disease and future asthma risk.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Respiratory Syncytial Virus (RSV) is a primary cause of pediatric lower respiratory tract infections (LRTI) and hospitalizations worldwide.
  • Several factors, including infant demographics (gender, age, gestational age, birth weight) and environmental exposures (tobacco smoke, breastfeeding), may influence RSV disease severity and long-term outcomes.
  • The American Academy of Pediatrics (AAP) established guidelines in 2006 for diagnosing and managing bronchiolitis, including prevention strategies.

Purpose of the Study:

  • To review the factors influencing the prevalence of RSV-related disease in infants.
  • To explore the potential link between RSV infection and the development of asthma-like symptoms in school-aged children.
  • To highlight the importance of current diagnostic and management guidelines for RSV bronchiolitis.

Main Methods:

  • Literature review of studies on RSV epidemiology and risk factors.
  • Analysis of demographic and environmental variables associated with RSV outcomes.
  • Examination of clinical guidelines for bronchiolitis management.

Main Results:

  • RSV is a significant global health burden in young children, leading to substantial hospitalizations.
  • Infant characteristics and environmental factors play a role in RSV disease prevalence and potentially in the development of asthma-like symptoms.
  • Established guidelines provide a framework for clinical decision-making in RSV management.

Conclusions:

  • Understanding risk factors is crucial for managing and preventing severe RSV infections in infants.
  • Further research may elucidate the connection between early RSV exposure and later respiratory health, such as asthma.
  • Adherence to AAP guidelines is essential for optimal care and prevention of RSV-related LRTI.

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.